{"transactions":[{"id":3222864,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":150919,"kind":"person","name":"Robinson Warren","position":1,"cik":"0001745569","reported_name":"Robinson Warren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T14:08:23.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of March 1, 2019 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":60000,"derivative":{"exercise_price":4.25,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-016872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745569/000120919120016872/doc4.xml","form_type":"4"}},{"id":3259748,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":150919,"kind":"person","name":"Robinson Warren","position":1,"cik":"0001745569","reported_name":"Robinson Warren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-20T19:25:26.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of February 18, 2020 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":120000,"derivative":{"exercise_price":1.04,"expiration_date":"2020-02-17","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-20-011299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745569/000120919120011299/doc4.xml","form_type":"4"}},{"id":3798956,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":150919,"kind":"person","name":"Robinson Warren","position":1,"cik":"0001745569","reported_name":"Robinson Warren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T16:30:15.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":64640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on October 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":64640,"derivative":{"exercise_price":7.77,"expiration_date":"2028-09-30","underlying":"Common Stock","underlying_shares":64640},"source":{"system":"sec-edgar","filing":"0001209191-18-053811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745569/000120919118053811/doc4.xml","form_type":"4"}}]}